4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-047942
Chief Medical Officer sold 12,500 shares at an average $50.95 ($636,855)
- Chief Medical Officer acquired 26,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Pang Phillip · Chief Medical Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-08-19 | Exercise or conversion : show line 1 in the form | +10,185 | $1.58 | $16,041 | 25,962 | D |
| 2020-08-19 | Exercise or conversion : show line 2 in the form | +2,315 | $5.18 | $11,980 | 28,277 | D |
| 2020-08-19 | Exercise or conversion : show line 3 in the form | +14,000 | $0.86 | $11,970 | 42,277 | D |
| 2020-08-19 | Sale : show line 4 in the form | −5,000 | $50.96 | $254,808 | 37,277 | D |
| 2020-08-19 | Sale : show line 5 in the form | −7,500 | $50.94 | $382,048 | 29,777 | D |
| Open-market sales · 12,500 sh · avg $50.95 · $636,855 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-08-19 | Exercise or conversion : show line 6 in the form Employee Stock Option (Right to Buy) | −10,185 | 75,462 | D |
| 2020-08-19 | Exercise or conversion : show line 7 in the form Employee Stock Option (Right to Buy) | −2,315 | 71,759 | D |
| 2020-08-19 | Exercise or conversion : show line 8 in the form Employee Stock Option (Right to Buy) | −14,000 | 81,333 | D |
Loading xslF345X03/doc4.xml…